112 related articles for article (PubMed ID: 10360439)
1. Quantitative high-performance liquid chromatographic method for pharmacokinetic studies of the potent mast cell inhibitor 4-(4'-hydroxyphenyl)amino-6,7-dimethoxyquinazoline (WHI-P131).
Chen CL; Malaviya R; Chen H; Liu XP; Uckun FM
J Chromatogr B Biomed Sci Appl; 1999 Apr; 727(1-2):205-12. PubMed ID: 10360439
[TBL] [Abstract][Full Text] [Related]
2. In vivo pharmacokinetics and anti-anaphylactic activity of the novel mast cell inhibitor 4-(4'-hydroxylphenyl)-amino-6,7-dimethoxyquinazoline (WHI-P131).
Malavija R; Chen CL; Liu XP; Uckun FM
Am J Ther; 2001; 8(1):35-9. PubMed ID: 11304656
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics and biologic activity of the novel mast cell inhibitor, 4-(3-hydroxyphenyl)-amino-6,7-dimethoxyquinazoline in mice.
Chen CL; Malaviya R; Navara C; Chen H; Bechard B; Mitcheltree G; Liu XP; Uckun FM
Pharm Res; 1999 Jan; 16(1):117-22. PubMed ID: 9950289
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of the antigen-induced activation of rodent mast cells by putative Janus kinase 3 inhibitors WHI-P131 and WHI-P154 in a Janus kinase 3-independent manner.
Linwong W; Hirasawa N; Aoyama S; Hamada H; Saito T; Ohuchi K
Br J Pharmacol; 2005 Jul; 145(6):818-28. PubMed ID: 15852029
[TBL] [Abstract][Full Text] [Related]
5. In vivo toxicity and pharmacokinetic features of the janus kinase 3 inhibitor WHI-P131 [4-(4'hydroxyphenyl)-amino-6,7- dimethoxyquinazoline.
Uckun FM; Ek O; Liu XP; Chen CL
Clin Cancer Res; 1999 Oct; 5(10):2954-62. PubMed ID: 10537365
[TBL] [Abstract][Full Text] [Related]
6. Structure-based design of specific inhibitors of Janus kinase 3 as apoptosis-inducing antileukemic agents.
Sudbeck EA; Liu XP; Narla RK; Mahajan S; Ghosh S; Mao C; Uckun FM
Clin Cancer Res; 1999 Jun; 5(6):1569-82. PubMed ID: 10389946
[TBL] [Abstract][Full Text] [Related]
7. Treatment of allergic asthma by targeting janus kinase 3-dependent leukotriene synthesis in mast cells with 4-(3', 5'-dibromo-4'-hydroxyphenyl)amino-6,7-dimethoxyquinazoline (WHI-P97).
Malaviya R; Chen CL; Navara C; Malaviya R; Liu XP; Keenan M; Waurzyniak B; Uckun FM
J Pharmacol Exp Ther; 2000 Dec; 295(3):912-26. PubMed ID: 11082424
[TBL] [Abstract][Full Text] [Related]
8. Targeting Janus kinase 3 in mast cells prevents immediate hypersensitivity reactions and anaphylaxis.
Malaviya R; Zhu D; Dibirdik I; Uckun FM
J Biol Chem; 1999 Sep; 274(38):27028-38. PubMed ID: 10480916
[TBL] [Abstract][Full Text] [Related]
9. CYP1A-mediated metabolism of the Janus kinase-3 inhibitor 4-(4'-hydroxyphenyl)-amino-6,7-dimethoxyquinazoline: structural basis for inactivation by regioselective O-demethylation.
Uckun FM; Thoen J; Chen H; Sudbeck E; Mao C; Malaviya R; Liu XP; Chen CL
Drug Metab Dispos; 2002 Jan; 30(1):74-85. PubMed ID: 11744615
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic nanoparticle constructs of a JAK3 tyrosine kinase inhibitor against human B-lineage ALL cells.
Uckun FM; Dibirdik I; Qazi S; Yiv S
Arzneimittelforschung; 2010; 60(4):210-7. PubMed ID: 20486472
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of human glioblastoma cell adhesion and invasion by 4-(4'-hydroxylphenyl)-amino-6,7-dimethoxyquinazoline (WHI-P131) and 4-(3'-bromo-4'-hydroxylphenyl)-amino-6,7-dimethoxyquinazoline (WHI-P154).
Narla RK; Liu XP; Klis D; Uckun FM
Clin Cancer Res; 1998 Oct; 4(10):2463-71. PubMed ID: 9796979
[TBL] [Abstract][Full Text] [Related]
12. Anti-allergic activity of 2,4,6-trihydroxy-3-geranylacetophenone (tHGA) via attenuation of IgE-mediated mast cell activation and inhibition of passive systemic anaphylaxis.
Tan JW; Israf DA; Harith HH; Md Hashim NF; Ng CH; Shaari K; Tham CL
Toxicol Appl Pharmacol; 2017 Mar; 319():47-58. PubMed ID: 28167223
[TBL] [Abstract][Full Text] [Related]
13. Anti-allergic actions of rottlerin from Mallotus philippinensis in experimental mast cell-mediated anaphylactic models.
Chan TK; Ng DS; Cheng C; Guan SP; Koh HM; Wong WS
Phytomedicine; 2013 Jul; 20(10):853-60. PubMed ID: 23632085
[TBL] [Abstract][Full Text] [Related]
14. Anti-allergic action of anti-malarial drug artesunate in experimental mast cell-mediated anaphylactic models.
Cheng C; Ng DS; Chan TK; Guan SP; Ho WE; Koh AH; Bian JS; Lau HY; Wong WS
Allergy; 2013 Feb; 68(2):195-203. PubMed ID: 23253152
[TBL] [Abstract][Full Text] [Related]
15. Quantitative high-performance liquid chromatography-based detection method for calphostin C, a naturally occurring perylenequinone with potent antileukemic activity.
Chen CL; Chen H; Zhu DM; Uckun FM
J Chromatogr B Biomed Sci Appl; 1999 Mar; 724(1):157-62. PubMed ID: 10202968
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic features and metabolism of calphostin C, a naturally occurring perylenequinone with antileukemic activity.
Chen CL; Tai HL; Zhu DM; Uckun FM
Pharm Res; 1999 Jul; 16(7):1003-9. PubMed ID: 10450923
[TBL] [Abstract][Full Text] [Related]
17. Treatment of atherosclerosis in apolipoprotein E-deficient mice with 4-(3-Bromobenzoyl)-6,7-dimethoxyquinazoline (WHI-P164), a potent inhibitor of triglyceride synthesis.
Trieu VN; Liu XP; Chen CL; Uckun FM
J Cardiovasc Pharmacol; 2000 Feb; 35(2):179-88. PubMed ID: 10672848
[TBL] [Abstract][Full Text] [Related]
18. Prevention of DMBA-induced mammary gland tumors in mice by a dual-function inhibitor of JAK3 and EGF receptor tyrosine kinases.
Sahin K; Yabas M; Orhan C; Tuzcu M; Sahin TK; Ozercan IH; Qazi S; Uckun FM
Expert Opin Ther Targets; 2020 Apr; 24(4):379-387. PubMed ID: 32106727
[No Abstract] [Full Text] [Related]
19. Repositioning of anti-cancer drug candidate, AZD7762, to an anti-allergic drug suppressing IgE-mediated mast cells and allergic responses via the inhibition of Lyn and Fyn.
Park YH; Kim DK; Kim HW; Kim HS; Lee D; Lee MB; Min KY; Koo J; Kim SJ; Kang C; Kim YM; Kim HS; Choi WS
Biochem Pharmacol; 2018 Aug; 154():270-277. PubMed ID: 29777684
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory effects of Acorus calamus extracts on mast cell-dependent anaphylactic reactions using mast cell and mouse model.
Kim DY; Lee SH; Kim WJ; Jiang J; Kim MK; Shin YK; Kim DW; Moon WK; Kwon SC; Koppula S; Kang TB; Lee KH
J Ethnopharmacol; 2012 May; 141(1):526-9. PubMed ID: 22366435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
